Something is causing the share price of the former Nasdaq listed Marina Biotech, Inc. (MRNA) to heat up this morning on no news or rumors. Three years ago, the penny stock was trading at 200 times it current price, around $80, before delisting and failing to file updated financials with the SEC. Yet, for some strange reason, MRNA stock is ...
Pot smokers who trade penny stocks all know about the marijuana focused companies and can tell you everything about how legalization is inevitable. However, one OTC listed biotech stock, Lightlake Therapeutics Inc (LLTP), may be a complimentary addition to their portfolio with their search to cure Binge Eating Disorder. LLTP stock doesn’t see near the volume traded that
Continue Reading →
30
Share
SEP
Shares of Ampio Pharmaceuticals Inc. (AMPE) are not having their best trading after analysts at Aegis set a “buy” rating and a $11.00 price target on the stock. Having seen $8.50 well back in October of last year, AMPE stock is not having the rally a biopharmaceutical company should have after being upgraded and agreeing with ...
Long investors in the penny stock of Cellceutix Corporation (CTIX) are finally seeing their patience pay off as they experience a September to remember. Since the beginning of the month, CTIX stock has rallied from 63 cents and volume of 83,000 shares to 1.18, nearly double, and a share volume increase of more than 17X. All the hype really began when ...
The penny stock of Titan Pharmaceuticals Inc. (TTNP) is making a hard push to returning above the one-dollar level after more positive news on Probuphine®. Ever since announcing a $5.5 million direct offering on April 10th, TTNP stock has been unable to return to above $1 per share, falling as low as 0.60 just four weeks ago. Today’s stock purchase ...
The OTC Market welcomed the recently delisted Nasdaq biotech firm, Tengion, Inc. (TNGN), with open arms sending its penny stock to a new 52 week low. Having failed to meet the Nasdaq requirement of a minimum $2.5 million stockholders’ equity, TNGN stock entered the gladiator arena of day traders and got flipped upside down to close -88.41% lower ...
“Honey honey, how you thrill me, ah-hah, honey honey” has been the theme for investors who bought into A.P. Pharma Inc. (APPA) prior to January 1, 2012. Without the issuance of one “SOS” all year, APPA stock has steadily climbed from 0.23 making the JMP Securities “outperform” rating and $3.00 price target issued in June look like a “Nina, ...
Tuesday is such a sorry trading session on the OTC that we thought we would take the opportunity to do some chest beating around here for new readers. In April, we touched on our theory that Peregrine Pharmaceuticals Inc. (PPHM) was at the bottom and ...
Frank Sinatra sung about making it in a city that doesn’t sleep which apparently also doesn’t donate much sperm either. With declining revenues, Proteonomix Inc. (PROT) dumped its only source of income, The Sperm Bank of New York in April, 2012. It didn’t matter since the spunk had little to do with PROT stock price appreciation in January. Yet, with ...
Surely, Pristine Solutions (PRTN) would have wanted to end the trading leading in both trades and dollar volume for all penny stocks off the news of their baby steps towards faking an FDA approval. However, going into the last few minutes f trading, the dollar volume ...
